As observed in Figure 2, metadata analysis showed that DDR2 gene level was higher in those invasive BC tumors with a more aggressive phenotype (p=0.0318), defined by the CCND1 amplification as metastatic marker [33]. Here, DDR2 is linked to breast cancer.